Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_4
2
25%
Ph phase_3
2
25%
Ph not_applicable
2
25%
Ph phase_2
2
25%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 32 (25.0%)
Phase 42 (25.0%)
N/A2 (25.0%)

Trials by Status

completed675%
unknown225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8